chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 03-25-2021, at 7pm, I started to feel flu  like symptoms with body aches but no congestion. In the morning it seemed getting better but then my symptoms got worse.  I took two Ibuprofen which helped. I still continued to feel tired. After my vaccine, I also got a weird taste in my mouth. I was very tired over the weekend. My armpit itched and so I scratched it and I felt raised bumps under my armpit, under the pit of my arms on both sides, right greater than left. My left arm was the one vaccinated. I also had bad diarrhea on 03-29-2021. Today I still continue with the rash under my armpits and still feel very tired and fatigued.
Large Red, slightly raised bumps on both elbows with mild pruritis.  Slightly puffy under eyes.
100.7 fever for two days  Very chilled and shaking for one day Ached all over for three days Greatly fatigued for a week On fourth day, clammy and sweaty for two days.
2 days post vaccine, 10/30/2021- I woke up deaf. I could not hear anything for like 20 minutes. A high pitch tone for lack of a better words. I could not hear anything out of either ear. I obviously freaked out, but it started to come back and I thought that was weird. It happened again and it happened more frequently. I have episodes where I hear a tone. My ear will pop and I will not be able to hear for a few moments, and it comes back. Sometimes I can't sleep because I hear a tone that I can't shut up. 11/18/2021-Doctor looked at my ears. I do not have a history of tinnitus. He said my ears look physically fine and referred me to a specialist. The doctor also ordered me a battery of blood work. This continues to happen frequently every day.
Heart palpitations, increased heart rate, sharp chest pain, elevated blood pressure, starting 11 days after 1st dose.
began screaming 45 mins p/vax was administered-screamed cont for 6 1/2 hrs;
This spontaneous report was received from a Medical Assistant referring to a currently 11 year old patient of unknown gender. On 10-MAY-2007, the patient was vaccinated with the first dose of PROQUAD (strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. On 12-MAR-2017, the patient received the second dose of PROQUAD (strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. It was reported that on 08-MAY-2017, the patient inadvertently received, due to human error, a third dose of PROQUAD (strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. No adverse event reported. Additional information has been requested.
8 cm x 12 cm erythematous rash with vesicles and 2 cm x 2 cm area of induration on the left upper arm at the site of the injection; pain to palpation; no fever; Benadryl given.
Had 1st dose on 12/18.202 and second dose on 1/8/2021 Contracted COVID 19 with symptoms starting on 7/3/2021... Tested positive on 7/72021.
Narrative:  swollen lymph onodes for 2-3 days, headache/migraine on 2nd day swollen lymph nodes
Initial report received from a health care professional on 21 Dec 2010: This 15 months old patient was inadvertently vaccinated with 0.5 ml MENVEO (batch number: 100023), intramuscularly on 10 Nov 2010. No adverse events were noted following this medication error.
very painful arm that lasted weeks; Stomach ache; Diarrhea; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (very painful arm that lasted weeks), ABDOMINAL PAIN UPPER (Stomach ache), DIARRHOEA (Diarrhea), HEADACHE (Headache) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (very painful arm that lasted weeks), ABDOMINAL PAIN UPPER (Stomach ache), DIARRHOEA (Diarrhea), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (very painful arm that lasted weeks) had resolved and ABDOMINAL PAIN UPPER (Stomach ache), DIARRHOEA (Diarrhea), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication were provided.
Headache, Myalgia, Fever, She received the Moderna vaccine 2nd dose on 2/1 and states that she began to experience soreness at the injection site, fever, bodyaches/chills, and nausea. Called out of work on 2/2, 2/3 Narrative:
Pt's mom states pt started vomiting in car 15 mins after injection. Pt became listless and felt hot. Pt's face red and pt shaking. Arrived home. Pt given Tylenol called office around 3:10pm temp 103 axillary. Pt to be brought to office. 3:45 pt temp 100.2 degrees BP 100/60, pulse reg. Pt talkative and playful.
Experiencing vision blurriness, dry eyes, - utilizes eye drops and resolves.  Feels "heavy" some sneezing too.
Sore arm; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore arm) and FATIGUE (Tiredness) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bladder cancer, Kidney cancer and Prostate cancer.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced INJECTION SITE PAIN (Sore arm) and FATIGUE (Tiredness). At the time of the report, INJECTION SITE PAIN (Sore arm) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication nor treatment information provided.  Patient has difficulty in getting for dose 2 vaccine, earliest date are given after 45 days of 1st vaccine.
Pt reported feeling weak and tired, like he was about to have a MS relapse during refill consult for MS medication.  His second dose of CoVID Moderna was received on 2/25/2021.  Advised common reaction to feel fatigued and weak esp after second dose.  If it were to continue past 5 days consider follow up with neurologist to r/o relapse.
I can't move well because my back hurts me; back in the bottom and my legs too; I can't move well because my back hurts me; back in the bottom and my legs too; I can't move well because my back hurts me; back in the bottom and my legs too; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 15May2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious), PAIN IN EXTREMITY (non-serious), MOBILITY DECREASED (non-serious) all with onset 16May2021, outcome "unknown" and all described as "I can't move well because my back hurts me; back in the bottom and my legs too".  Additional information: Reported that, Yesterday (at the time of reporting, 15May2021), patient (Pt) got the Pfizer Covid-19 Vaccine and today (16May2021) morning Pt back hurts and Pt do not know why, cannot move well because back hurts, back in the bottom and legs too. Pt called about an advice.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A non-serious spontaneous report of fever, runny nose, stuffy nose and feels like a cold has been received from a non-health professional concerning an adult female, subsequent to FLUMIST. Neither the patient's past medical history nor the concomitant medications were reported. The patient received FLUMIST nasally on 10-Nov-2010 for Influenza prevention. By Thursday, on 11-Nov-2010, the patient experienced a fever that lasted one day and nose was stuffy and running. The stuffy runny nose had continued and she felt like a cold. The outcome of fever was resolved, while that of stuffy nose, runny nose and feels like a cold was not recovered.
This 41-month-old male received 4 doses of Haemophilus b conjugate vax. Subsequent to the 4th vax on 11/16/1992, he developed bacteremia. Haemophilus influenzae type B was revealed by a blood culture. Upon internal review, the pt's experience was considered to be an "other medical event."  The pt's outcome was reported as "survived." This was reported as case of vax failure. No further information is available.
Patient received all 3 vaccines listed above and tolerated well. He was released to front waiting area to wait for his certificate of immunization 5 minutes after vaccine was given. Once he walked to the front lobby he had a syncopal episode. Patient did not lose consciousness and was alert and oriented x 3.  He was pale and diaphoretic. He was set up in chair with feet elevated, cool rag applied to neck, and was monitored by RN. RN gave him a lollipop and a can of cola and monitored patient x 15 minutes.   His color returned and diaphoresis resolved so RN released patient in the care of his mother and a friend that accompanied them that was a nurse.
Within 48 hours post vax, she developed a rash and hives. She recovered.
sore in every where, like a flu.; sore in every where, like a flu; Having nausea ( very nausea); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore in every where, like a flu.), INFLUENZA LIKE ILLNESS (sore in every where, like a flu) and NAUSEA (Having nausea ( very nausea)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 015M20A) for COVID-19 vaccination.     The patient's medical history was not provided. No relevant concomitant medications were reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (sore in every where, like a flu.) and INFLUENZA LIKE ILLNESS (sore in every where, like a flu). 04-Mar-2021, the patient experienced NAUSEA (Having nausea ( very nausea)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (sore in every where, like a flu.), INFLUENZA LIKE ILLNESS (sore in every where, like a flu) and NAUSEA (Having nausea ( very nausea)) outcome was unknown. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.  The outcome of events, having nausea (very nausea), sore in everywhere, like a flu was unknown.
Information has been received from a registered pharmacist concerning nine patients of unknown age and gender. On unspecified dates, the patients were vaccinated subcutaneously with a 0.65 ml ZOSTAVAX (frequency was not reported) (Lot #: H011427; Expiration date: 12-SEP-2013), that had been improperly stored, exposed to 40F for 30 days. There were no adverse effects. Additional information has been requested.
This case was reported by a physician and described the occurrence of erythema in a 7-year-old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (Dtpa, manufacturer unspecified) for prophylaxis. In April 2007 the subject received an unspecified dose of Dtpa (.5 ml, unknown, left arm). At an unspecified time after vaccination with Dtpa, the subject experienced erythema, extensive swelling of vaccinated limb, itching and drug maladministration. A physician reported that during a conversation he heard another physician mention that they vaccinated a female subject who was 7 years and 4 months old with a diphtheria, tetanus and pertussis (Dtpa) vaccine. At the site of administration, the subject developed swelling (extensive swelling of vaccinated limb) and redness in a 4 by 6 inch area. The physician stated that he did not think the subject received any other vaccinations on the same day that Dtpa was administered. However, the reporting physician was not the physician who administered the vaccine, nor was it administered at his practice. Unspecified medical attention was required at the physician's office.
Raised welt appeared 8 days after shot was received.  Area is sensitive, warm to the touch and itchy at times.  Symptoms and onset are exactly the same as those mentioned in the following article:
Palpitation after 2nd shot; Shortness Of Breath after 2nd shot; Weakness after 2nd shot; Feel Inflammation in the chest after 2nd shot; Dizziness after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitation after 2nd shot), DYSPNOEA (Shortness Of Breath after 2nd shot), ASTHENIA (Weakness after 2nd shot), CHEST DISCOMFORT (Feel Inflammation in the chest after 2nd shot) and DIZZINESS (Dizziness after 2nd shot) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Exposure to COVID-19 (Never did a PCR test, had COVID symptoms for 1 day only) in 2020.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PALPITATIONS (Palpitation after 2nd shot), DYSPNOEA (Shortness Of Breath after 2nd shot), ASTHENIA (Weakness after 2nd shot), CHEST DISCOMFORT (Feel Inflammation in the chest after 2nd shot) and DIZZINESS (Dizziness after 2nd shot). At the time of the report, PALPITATIONS (Palpitation after 2nd shot), DYSPNOEA (Shortness Of Breath after 2nd shot), ASTHENIA (Weakness after 2nd shot), CHEST DISCOMFORT (Feel Inflammation in the chest after 2nd shot) and DIZZINESS (Dizziness after 2nd shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Heart rate: fast heart beat (High) Fast heart beat. On an unknown date, Electrocardiogram: normal (normal) He is not having a heart attack.         No concomitant medications were reported. No treatment medications were reported. Patient reported that after second dose of vaccination he was not the same, he felt inflammation in his chest, he had experienced symptoms of myocarditis. He went to the Emergency Room several times and after EKG was performed he was told that he is not having a heart attack and to follow up with cardiologist. he did not have any history of myocarditis.
adverse reaction: none; pneumonia vaccine every year since 2015; Information has been received from a lawyer and an elderly female patient via a Plaintiff Fact Sheet referring to the patient. The patient was a non-smoker. Information regarding medical history, concurrent conditions and concomitant medications was not reported.  On unknown date in 2015, the patient received pneumonia vaccine (manufacturer unknown) (dose, route, lot number and expiration date were not provided) for prophylaxis. It was reported that the patient received the pneumonia vaccine (manufacturer unknown) every year since 2015 (inappropriate schedule of product administration). The patient did not experience any adverse reaction or side effects.  This is one of two cases for the same patient (link # 2012USA012896).; Sender's Comments:  US-009507513-2012USA012896:
2 days after the vaccine, developed Right Lower Quadrant pain - varying in severity from 2 to 7 out of 10, intermittent.   Suspected mesenteric adenitis, possibly secondary to vaccination.  DDx includes appendicitis.  Plan - observe at home, follow up if worsening symptoms or not resolving later this week.
A legal complaint was received from an attorney alleging that a male plaintiff received 5 doses of Orimune vaccine during the time period of September 1973 through August 1976. The legal complaint states that the Orimune administered contained the contaminant/adulterant, SV40, and ultimately caused the development of a cancerous brain tumor in the plaintiff. Medical records indicate that the plaintiff presented in November 200 with the insidious onset of headaches associated with nausea and vomiting. He was seen in the emergency room and was noted to have papilledema. A computerized tomogram reveealed posterior fossa and a nuclear magnetic resonance imaging revealed a 4.5 x 4.0 x 4.6 cm posterior superior vermian intra-axial mass with tonsillar herniation and secondary hydrocephalus. He was hospitalized and diagnosed with medulloblastoma. On 27-Nov-2000, he underwent a suboccipital craniotomy with steriotactic volumetric resection of the large cerebral tumor. A pathology report stated taht the tumor was a meduloblastoma involving the leptomeninges extending down the Virchow-Robin space of the cerebral cortex. The plaintiff was to further undergo chemotherapy and cranial spinal radiation therapy.
flashes / About 20 hours post injection chills ended and were replaced by hot flashes; About 12 hours post injection, chills started with body aches and while body shakes from chills; aches / body aches; headache worsened; Soreness/muscle stiffness around injection site; Soreness/muscle stiffness around injection site; headache; tiredness / whole body fatigue; This is a spontaneous report from a non-contactable consumer (patient). A 42-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in left arm on 17Feb2021 at 11:00 AM (age at vaccination was 42 years) as dose 2, single for COVID-19 immunisation. Medical history and concomitant medications were not reported.Patient had no known allergies.The patient was not received other vaccine in four weeks and not received other medications in two weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EN9581) administered in right arm on 27Jan2021 (age at vaccination was 42 years) as dose 1, single for COVID-19 immunisation. On 17Feb2021 at 02:00 PM, the patient was experienced soreness/muscle stiffness around injection site. About 3 hours post injection (on 17Feb2021 at 02:00 PM), headache tiredness, whole body fatigue. About 12 hours post injection (On 17Feb2021 at 11:00 PM), chills started with body aches and while body shakes from chills, headache worsened. About 20 hours post injection (On 18Feb2021 at 07:00 AM) chills ended and were replaced by hot flashes, severe headache persisted. The patient did not received any treatment for adverse events. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a healthcare worker, refers to a patient of unknown age and gender. No pertinent medical history, concurrent conditions or drug reactions/ allergies were reported. On 07-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9, which had a lot # of L016428 and an expiration date of 30-AUG-2017 (dose, dosage number, route of administration and anatomical location were not reported). It was stated that the temperature excursion was 28.9 F for a time frame of 7 hours. This excursion was found due to a data logger. Additionally, it was stated that no previous temperature excursions had occurred. This is one of the several reports received from the same reporter. Additional information has been requested.
got Guillain-Barre syndrome; This spontaneous case was reported by an other health care professional and describes the occurrence of GUILLAIN-BARRE SYNDROME (got Guillain-Barre syndrome) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GUILLAIN-BARRE SYNDROME (got Guillain-Barre syndrome) (seriousness criterion medically significant). At the time of the report, GUILLAIN-BARRE SYNDROME (got Guillain-Barre syndrome) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.  Very limited information regarding this event has been provided at this time.; Sender's Comments: Very limited information regarding this event has been provided at this time.
1/30/00, developed fever (mom did not take temp). Rash developed all over body-erythemic macules. No itching noted. Child seen by Dr on 1/31/00. No change in rash. Fever has subsided & child is playing, eating, drinking normally.
This spontaneous report was received from a physician via two company representatives and from a practice manager (support services director) and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 16-JUN-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 10 microgram/1 ml injection, lot # L044917, expiration date 05-OCT-2018 (dose, route and site of administration were not reported). The administered dose of vaccine was exposed to two temperature excursions (dates unspecified): one lasting for 72 hours, with the lowest recorded temperature of 31 degrees Fahrenheit (-0.555555556 degrees Celsius) and another lasting for 144 hours, with the lowest recorded temperature of 34 degrees Fahrenheit (1.111111111 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.